News

Global CEO Summit at NYSE

At the iconic NYSE, Sharon Chen presented AlphaLife Sciences' strategic vision to an exclusive audience of life sciences CEOs and Johnson & Johnson senior executives. Her presentation focused on the company’s transformative platform, AuroraPrime, which leverages advanced generative AI to enhance medical writing and clinical documentation, driving accelerated timelines in drug development. Sharon outlined AlphaLife’s unique approach and sustainable growth strategies, sharing tangible outcomes achieved by global biopharma clients through GenAI-driven automation. This summit provided an invaluable platform for strategic connections and insights into fostering innovation and collaboration across the sector.

APAC CEO Summit and JLABS Singapore Anniversary Celebration

Following the Global Summit, Sharon participated in the APAC CEO Summit in Singapore, where she shared her entrepreneurial journey, reflecting on the resilience, vision, and dedication that shaped AlphaLife Sciences. She underscored the company’s commitment to advancing drug development through AuroraPrime and to delivering solutions that enhance critical clinical processes. In celebration of JLABS Singapore’s first anniversary at the SGX Group Singapore Exchange, Sharon joined leaders from the Asia-Pacific region in discussions on collaboration, funding, and the transformative role of GenAI in life sciences.

We extend our gratitude to the JLABS team for organizing these impactful events and extend a special thanks to Sharon Chan (Head of JLABS APAC), Dr. Alessandro Falcone (Head of JLABS Singapore), and Melinda Richter (Global Head of JLABS) for their invaluable support. These summits have reinforced our commitment to advancing drug development and healthcare innovation. We look forward to continued collaboration and shared success on this transformative journey.